


































Opioid weaning in 
critically ill children
Source: Sanchez-Pinto LN, Nelson LP, Lieu P, Koh J, Rodgers J, Larson K, Huson J, Amirnovin R. 
Implementation of  a risk-stratified opioid weaning protocol in a pediatric intensive care unit J Crit Care 
2018; 43:214-219.
This study aimed to implement a risk-stratified opioid weaning protocol. Its rationale is to reduce the duration of  opioid use in the care of  critically ill children without increasing the incidence of  withdrawal syndrome. It 
was prospectively conducted in a large children’s hospital pediatric intensive care 
unit (PICU) with 107 children younger than 21 years of  age who received scheduled 
opioids for at least seven days during their admission to the PICU. The 24-bed 
tertiary PICU serves a wide range of  patients: medical, surgical, trauma, and solid-
organ and hematopoietic stem cell transplantation patients, but not postoperative 
cardiac patients. Two groups of  patients were compared: pre and post-protocol 
implementation. In the pre-intervention period, opioid weaning was at the discretion 
of  the treating physicians.
To apply the weaning protocol, the authors first used an algorithm to stratify 
each patient risk of  withdrawal in low, moderate, high or very high. The opioid 
infusion dose was then converted to a weaning medication (either intravenous 
hydromorphone or oral methadone, according to the patient’s risk of  withdrawal), 
and withdrawal signs and symptoms were assessed regularly using the Withdrawal 
Assessment Tool (WAT-1). The primary outcome was duration of  opioid exposure, 
measured using the total length of  scheduled opioids and the length of  opioid weaning. 
Total exposure to opioids was also calculated as cumulative morphine equivalents 
(mg/Kg/patient) from initiation of  opioids until the last dose of  scheduled weaning 
opioid. The secondary outcomes included hospital length of  stay, number of  patients 
discharged home on opioids, and protocol compliance.
The mean age was similar in both groups: 2.1 and 2.3 years in the pre and post-
intervention groups respectively. In the post-intervention group, 15 patients (38%) 
met moderate-risk, 23 patients (59%) met high-risk, and 1 patient (3%) met very high-
risk for withdrawal criteria. Protocol implementation decreased the total length of  
scheduled opioids, the length of  opioid weaning and total exposure to opioids (33.2 
vs 48.8 mg/kg/patient, p=0.02). The reduction in hospital length of  stay in the post-
intervention group was not statistically significant. The number of  patients discharged 
home on opioids was not different. Protocol compliance in the post-intervention group 
was very high. Protocol-driven opioid weaning did not increase adverse events such as 
withdrawal symptoms, rescue opioid or naloxone doses or unplanned extubations.
The authors conclude that the purpose of  the protocol implementation, that 
is, reducing opioid exposure without increasing opioid withdrawal syndrome, was 
achieved, which is consistent with previous studies. They highlight the importance of  
monitoring withdrawal signs and symptoms in the advance of  the weaning protocol, 
especially for those patients who present withdrawal signs or symptoms from other 
causes. Risk stratification ensures a tailored approach for each patient, increasing the 
chances of  successful weaning as well as maximizing protocol acceptability by health 
care professionals. 
Commentary by: Letícia Massaud-Ribeiro, MD.



































This is a large study that tested the use of  an opioid weaning protocol in various 
profiles of  critically ill children, except for cardiac surgery patients. Nevertheless, 
this population of  postoperative cardiac patients was tested separately by the same 
research group with a similar study design and results, but with statistically significant 
reduction in hospital length of  stay.1 So results can overall be considered consistent. 
However, both are single-center studies and need to be replicated externally for the 
results to be validated.
One particular aspect that needs to be pointed out is that there was no other 
weaning protocol before the implementation of  this risk-stratified opioid weaning 
protocol. Weaning, as well as sedation, was at the discretion of  the treating physician. 
It is possible that the intervention in this study that most influenced the outcomes 
was the implementation of  the protocol itself, regardless of  its methods, since there 
was absolutely no recommendation to physicians before. The absence of  a sedation 
protocol, however, does not seem to have influenced the results, since exposure to 
adjunct medications was similar between groups.
In general, intensive care interventions are associated with better outcomes 
when driven by protocols rather than at the discretion of  the bedside team. 
Improvements in outcomes have been similarly demonstrated for other widely used 
interventions, such as sedation,2 neuromuscular blockade,3,4 mechanical ventilation 
weaning5 and, most notably, sepsis management.6 Sedation and analgesia management 
outcomes are closely related to opioid weaning. Current recommendations favor the 
use of  goal-directed sedation protocols, which can decrease opioid exposure and, as a 
result, duration of  the opioid weaning phase, with less withdrawal signs and symptoms. 
Sedation and analgesia management in particular is a widely variable. 
intervention across PICUs. Apart from all the outcome benefits of  protocol-driven 
care, the use of  goal-directed sedation and weaning protocols reduces variability of  
these practices within the PICU, making it more uniform and rendering practitioners 
more conscious of  the risks and benefits of  their management decisions, putting the 
clinical knowledge base developed in the protocol into everyday practice.
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